1. King JN, Arnaud JP, Goldenthal EI, et al (2011) Robenacoxib in the dog: target species safety in relation to extent and duration of inhibition of COX-1 and COX-2. J Vet Pharmacol Ther 34(3):298–311.2. Silber HE, Burgener C, Letellier IM, et al (2010) Population pharmacokinetic analysis of blood and joint synovial fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis. Pharm Res 27(12):2633–2645. 3. Previcox® Summary of Product Characteristics. 4. Metacam® Summary of Product Characteristics. 5. Rimadyl® Chewable Tablets US package insert. Onsior tablets for dogs (5 mg, 10 mg, 20 mg, 40 mg) are indicated for the treatment of pain and inflammation associated with soft tissue surgery and for the treatment of pain and inflammation associated with chronic osteoarthritis in dogs. Onsior solution for injection for cats and dogs (20 mg) is indicated for the treatment of pain and inflammation associated with orthopaedic or soft tissue surgery in dogs. COX-2 = cyclooxygenase-2.
Onsior POM-V (UK) and POM (Ireland) contains robenacoxib.
Further information is available from the SPC. Advice should be sought from the Medicine Prescriber. Refer to the product packaging and leaflets for information about side effects, precautions, warnings and contra-indications. Contact Elanco Animal Health for further information on 01256 353131 or email firstname.lastname@example.org, or write to: Elanco Animal Health, Form 2, Bartley Way, Bartley Wood Business Park, Hook, RG27 9XA.
Onsior, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.
© 2021 Elanco or its affiliates. PM-IE-21-0041. Date of preparation: 03/21.Use medicines responsibly www.noah.co.uk/responsible, www.apha.ie.